LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Immunovant (NASDAQ: IMVT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ IMVT Immunovant
Gloria Melanie / officer: Chief Operating Officer
11/18/2024
Buy
$25.51
137,446
$3.506M
137,446
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
10/23/2024
Sell
$29.53
4,361
$129K
322,878
NASDAQ IMVT Immunovant
Geffner Michael / officer: Chief Medical Officer
10/23/2024
Sell
$29.53
3,189
$94K
134,971
NASDAQ IMVT Immunovant
Stout Jay S / officer: Chief Technology Officer
10/23/2024
Sell
$29.53
2,740
$81K
142,186
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
10/16/2024
Sell
$28.79
9,095
$262K
994,789
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
10/16/2024
Sell
$28.79
2,627
$76K
365,705
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
10/16/2024
Sell
$28.79
561
$16K
365,144
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
10/16/2024
Sell
$28.79
2,860
$82K
327,239
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
10/16/2024
Sell
$28.79
3,271
$94K
335,343
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
10/09/2024
Sell
$29.56
5,162
$153K
338,614
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
10/09/2024
Sell
$29.56
4,460
$132K
1.00M

COPYRIGHT ©2023 HEALTH STOCKS HUB